Lung‐Sheng Wu

Chiayi Chang Gung Memorial Hospital — Taiwan

Medicine · Health Sciences

25h-index2.2kcitations78works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atrial Fibrillation Management and Outcomes(26), Cardiac Arrhythmias and Treatments(19), Cardiac pacing and defibrillation studies(14), Venous Thromboembolism Diagnosis and Management(9), Cardiovascular Function and Risk Factors(8)

Publications77 total

Effect of Direct-Acting Antiviral Therapy on Glycemic Control in Patients with Chronic Hepatitis C and Type 2 Diabetes: A Systematic Review and Meta-Analysis
Viruses·2026Open Access
A Self-Expanding Nitinol Fixation System for Atrial Leadless Pacemakers: Biomechanical Design and Evaluation
Bioengineering·2025· 1 citedOpen Access
The Prognostic Significance of Sleep and Circadian Rhythm for Myocardial Infarction Outcomes: Case-Control Study
Journal of Medical Internet Research·2025· 5 citedOpen Access
The prognosis of patients with myocardial infarction after light therapy: A preliminary study
Biomedical Journal·2024· 4 citedOpen Access
The Prognostic Significance of Sleep and Circadian Rhythm for Myocardial Infarction Outcomes: Case-Control Study (Preprint)
2024
Leadless pacemaker implementation at the right atrial appendage apex: An initial preclinical assessment
Pacing and Clinical Electrophysiology·2024· 2 citedOpen Access
Clinical significance of regional constructive and wasted work in patients receiving cardiac resynchronization therapy
Frontiers in Cardiovascular Medicine·2024· 1 citedOpen Access
Osteopontin mediation of disturbed flow–induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access
Kidney International·2023· 50 citedOpen Access
Upregulation of Myocardial Neutrophil Gelatinase-Associated Lipocalin during Development of Heart Failure Caused by Volume-Overload and the Effect in Regulating Activity of Matrix Metalloproteinase-9.
PubMed·2022· 1 citedOpen Access
Feasibility assessment of proton treatment for ventricular tachycardia—treatment planning study
Therapeutic Radiology and Oncology·2022· 1 citedOpen Access
Predicting Axial Length From Choroidal Thickness on Optical Coherence Tomography Images With Machine Learning Based Algorithms
Frontiers in Medicine·2022· 13 citedOpen Access
Derangements and Reversibility of Energy Metabolism in Failing Hearts Resulting from Volume Overload: Transcriptomics and Metabolomics Analyses
International Journal of Molecular Sciences·2022· 3 citedOpen Access
B-PO02-042 ENHANCED DETECTION OF CARDIAC ARRHYTHMIAS UTILIZING 14-DAY CONTINUOUS ECG PATCH MONITORING
Heart Rhythm·2021
Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants
Stroke·2021· 32 cited
Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis
Cardiovascular Drugs and Therapy·2020· 37 cited
Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor
Cardiovascular Diabetology·2020· 40 citedOpen Access
THU0424 SHORT-TERM ADHERENCE OF URATE-LOWERING AGENTS WILL NOT IMPROVE END-STAGE RENAL DISEASE AND MORTALITY
Annals of the Rheumatic Diseases·2020· 1 cited
Effectiveness, Safety, and Major Adverse Limb Events in Atrial Fibrillation Patients with Concomitant Diabetes Mellitus Treated with Non-Vitamin K Antagonist Oral Anticoagulants
Research Square (Research Square)·2020Open Access
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
Cardiovascular Diabetology·2020· 46 citedOpen Access
Effectiveness, Safety, and Major Adverse Limb Events in Atrial Fibrillation Patients with Concomitant Diabetes Mellitus Treated with Non-Vitamin K Antagonist Oral Anticoagulants
Research Square (Research Square)·2020Open Access
page 1 of 4Next →

Frequent Co-authors

Yung‐Hsin Yeh(29), Chi‐Tai Kuo(27), Yi‐Hsin Chan(24), Shang‐Hung Chang(21), Lai‐Chu See(21), Hsin‐Fu Lee(18), Pao‐Hsien Chu(15), Jia‐Rou Liu(13), Chunli Wang(11), Lung‐An Hsu(10), Hui‐Tzu Tu(9), Ying‐Chang Tung(9), Chee‐Jen Chang(8), Ming‐Shien Wen(6), Tze‐Fan Chao(6), Gregory Y.H. Lip(6), Yu‐Sheng Lin(5), Chia‐Pin Lin(5), Pei‐Ru Li(5), Chia-Tung Wu(5)